Associations of Plasma Concentrations of Dichlorodiphenyldichloroethylene and Polychlorinated Biphenyls with Prostate Cancer: A Case–Control Study in Guadeloupe (French West Indies)
Endocrine Disrupting Chemicals; Prostate Cancer; PCB; DDE; French West Indies; Guadeloupe
Abstract :
[en] Background: Long-term exposure to persistent pollutants with hormonal properties (endocrine-disrupting chemicals, EDCs) may contribute to the risk of prostate cancer (PCa). However, epidemiological evidence remains limited.
Objectives: We investigated the relationship between PCa and plasma concentrations of universally widespread pollutants, in particular p,p’-
dichlorodiphenyl dichloroethene (DDE) and the non-dioxin like polychlorinated biphenyl congener 153 (PCB153).
Methods and Findings: We evaluated before treatment 576 men with newly diagnosed PCa and 655 controls in Guadeloupe (French West Indies). Exposure was analyzed according to case-control status. Associations were assessed by unconditional logistic regression analysis, controlling for confounding factors. Missing data were handled by multiple imputation. We
estimated a significant positive association between DDE and PCa (adjusted odds ratio [OR] 1.53; 95% CI 1.02, 2.30 for the highest versus lowest quintile of exposure; PTrend= 0.01). PCB153 was inversely associated with PCa (OR 0.30; 95% CI 0.19, 0.47 for the highest versus lowest quintile of exposure values; PTrend<0.001). Also, PCB153 was more strongly associated to low-grade than high grade PCa.
Conclusions: Associations of PCa with DDE and PCB153 were in opposite directions. This may reflect differences in the mechanisms of action of these EDCs, and although our findings need to be replicated in other populations, they are consistent with complex effects of EDCs on human health.
Disciplines :
Oncology
Author, co-author :
Emeville, Elise; Institut National de la Santé et de la Recherche Médicale - INSERM > UMR 1085 > IRSET
Giusti, Arnaud ; Université de Liège - ULiège > Département de Biologie, Ecologie et Evolution > Département de Biologie, Ecologie et Evolution
Coumoul, Xavier; Institut National de la Santé et de la Recherche Médicale - INSERM > UMR-S 747 > Toxicologie Pharmacologie et Signalisation Cellulaire
Thomé, Jean-Pierre ; Université de Liège - ULiège > Département de Biologie, Ecologie et Evolution > Ecologie animale et écotoxicologie
Blanchet, Pascal; Centre Hospitalier Universitaire Guadeloupe > Service d'Urologie
Multigner, Luc; Institut National de la Santé et de la Recherche Médicale - INSERM > UMR 1085 > IRSET
Language :
English
Title :
Associations of Plasma Concentrations of Dichlorodiphenyldichloroethylene and Polychlorinated Biphenyls with Prostate Cancer: A Case–Control Study in Guadeloupe (French West Indies)
Publication date :
April 2015
Journal title :
Environmental Health Perspectives
ISSN :
0091-6765
Publisher :
US Dept Health Human Sciences Public Health Science, Research Triangle Park, Pakistan
Volume :
123
Issue :
4
Pages :
317-323
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
French National Health Directorate LNCC - Ligue Nationale Contre le Cancer
Alavanja MC, Samanic C, Dosemeci M, Lubin J, Tarone R, Lynch CF, et al. 2003. Use of agricultural pesticides and prostate cancer risk in the Agricultural Health Study cohort. Am J Epidemiol 157:800–814.
Aronson KJ, Wilson JW, Hamel M, Diarsvitri W, Fan W, Woolcott C, et al. 2010. Plasma organochlorine levels and prostate cancer risk. J Expo Sci Environ Epidemiol 20:434–445.
Bergman Å, Andersson AM, Becher G, van den Berg M, Blumberg B, Bjerregaard P, et al. 2013. Science and policy on endocrine disrupters must not be mixed: a reply to a “common sense” intervention by toxicology journal editors. Environ Health 12:69; doi:10.1186/1476-069X-12-69.
Bernert JT, Turner WE, Patterson DG Jr, Needham LL. 2007. Calculation of serum “total lipid” concentrations for the adjustment of persistent organo-halogen toxicant measurements in human samples. Chemosphere 68:824–831.
Carruba G. 2007. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario. J Cell Biochem 102:899–911.
Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. 2012. International varia-tion in prostate cancer incidence and mortality rates. Eur Urol 61:1079–1092.
Centers for Disease Control and Prevention. 2009. Fourth Report on Human Exposure to Environmental Chemicals. Atlanta, GA:U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Available: http://www.cdc.gov/exposurereport/pdf/FourthReport.pdf [accessed 11 November 2014].
Christensen CH, Platz EA, Andreotti G, Blair A, Hoppin JA, Koutros S, et al. 2010. Coumaphos exposure and incident cancer among male partici-pants in the Agricultural Health Study (AHS). Environ Health Perspect 118:92–96; doi:10.1289/ehp.0800446.
Colborn T, vom Saal FS, Soto AM. 1993. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 101:378–384.
Cooke PS, Sato T, Buchanan DL. 2001. Disruption of steroid hormone signaling by PCBs. In: PCBs: Recent Advances in Environmental Toxicology and Health Effects (Robertson LW, Hansen LG, eds). Lexington, KY: University Press of Kentucky, 257–263.
Damber JE, Aus G. 2008. Prostate cancer. Lancet 371:1710–1721.
Debier C, Pomeroy PP, Dupont C, Joiris C, Comblin V, Le Boulengé E, et al. 2003. Quantitative dynamics of PCB transfer from mother to pup during lactation in UK grey seals Halichoerus grypus. Mar Ecol Prog Ser 247:237–248.
Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, et al. 2009. Endocrine- disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev 30:293–342.
Dickerson SM, Cunningham SL, Patisaul HB, Woller MJ, Gore AC. 2011. Endocrine disruption of brain sexual differentiation by developmental PCB exposure. Endocrinology 152:581–594.
Dietrich DR, Aulock Sv, Marquardt H, Blaauboer B, Dekant W, Kehrer J, et al. 2013. Scientifically unfounded precaution drives European Commission’s recommendations on EDC regula-tion, while defying common sense, well-established science and risk assessment principles [Editorial]. Chem Biol Interact 205:A1–A5.
Ellem SJ, Risbridger GP. 2009. The dual, opposing roles of estrogen in the prostate. Ann NY Acad Sci 1155:174–186.
Ellem SJ, Risbridger GP. 2010. Aromatase and regu-lating the estrogen:androgen ratio in the prostate gland. J Steroid Biochem Mol Biol 118:246–251.
Emeville E, Giton F, Giusti A, Oliva A, Fiet J, Thomé JP, et al. 2013. Persistent organochlorine pollutants with endocrine activity and blood steroid hormone levels in middle-aged men. PLoS One 8:e66460; doi:10.1371/journal.pone.0066460.
Fagin D. Toxicology: the learning curve. 2012. Nature 490:462–465.
Gore AC, Balthazart J, Bikle D, Carpenter DO, Crews D, Czernichow P, et al. 2013. Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich, et al. [Letter]. Endocrinology 154:3957–3960.
Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. 2001. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea poly-phenols. Proc Natl Acad Sci USA 98:10350–10355.
Hansen LG. 1998. Stepping backward to improve assessment of PCB congener toxicities. Environ Health Perspect 106(suppl 1):171–189.
Hsing AW, Chokkalingam AP. 2006. Prostate cancer epidemiology. Front Biosci 11:1388–1413.
IARC (International Agency for Research on Cancer). 1991. Occupational exposures in insecticide appli-cation, and some pesticides. IARC Monogr Eval Carcinog Risk Hum 53:179–250.
Kelce WR, Lambright CR, Gray LE Jr, Roberts KP. 1997. Vinclozolin and p,p´-DDE alter androgen-depen-dent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism. Toxicol Appl Pharmacol 142:192–200.
Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, Wilson EM. 1995. Persistent DDT metabolite p,p’-DDE is a potent androgen antagonist. Nature 376:581–585.
Koutros S, Beane Freeman LE, Lubin JH, Heltshe SL, Andreotti G, Barry KH, et al. 2013. Risk of total and aggressive prostate cancer and pesticide use in the Agricultural Health Study. Am J Epidemiol 177:59–74.
Kupelian PA, Reddy CA, Reuther AM, Mahadevan A, Ciezki JP, Klein EA. 2006. Aggressiveness of Familial Prostate Cancer. J Clin Oncol 24:3445–3450.
Li J, Li N, Ma M, Giesy JP, Wang Z. 2008. In vitro profiling of the endocrine disrupting potency of organochlorine pesticides. Toxicol Lett 183:65–71.
Little RJA, Rubin DB. 1987. Statistical Analysis with Missing Data. New York:John Wiley & Sons.
Lynch SM, Mahajan R, Beane Freeman LE, Hoppin JA, Alavanja MC. 2009. Cancer incidence among pesticide applicators exposed to butylate in the Agricultural Health Study (AHS). Environ Res 109:860–868.
Mahajan R, Bonner MR, Hoppin JA, Alavanja MC. 2006. Phorate exposure and incidence of cancer in the Agricultural Health Study. Environ Health Perspect 114:1205–1209; doi:10.1289/ehp.8911.
McFarland VA, Clarke JU. 1989. Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congener-specific analysis. Environ Health Perspect 81:225–239.
Melchini A, Traka MH, Catania S, Miceli N, Taviano MF, Maimone P, et al. 2013. Anti proliferative activity of the dietary isothiocyanate erucin, a bioactive compound from cruciferous vegetables, on human prostate cancer cells. Nutr Cancer 65:132–138.
Morgan TO, Jacobsen SJ, McCarthy WF, Jacobson DJ, McLeod DG, Moul JW. 1996. Age-specific refer-ence ranges for prostate-specific antigen in black men. N Engl J Med 335:304–310.
Multigner L, Ndong JR, Giusti A, Romana M, Delacroix- Maillard H, Cordier S, et al. 2010. Chlordecone exposure and risk of prostate cancer. J Clin Oncol 28:3457–3462.
National Toxicology Program. 2014. Report on Carcinogens, 13th Report on Carcinogens (RoC). Research Triangle Park, NC:U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. Available: http://ntp.niehs.nih.gov/go/roc13 [accessed 11 November 2014].
Oh SM, Ryu BT, Lee SK, Chung KH. 2007. Antiestrogenic potentials of ortho-PCB congeners by single or complex exposure. Arch Pharm Res 30:199–209.
Owens W, Gray LE, Zeiger E, Walker M, Yamasaki K, Ashby J, et al. 2007. The OECD program to validate the rat Hershberger bioassay to screen compounds for in vivo androgen and antiandrogen responses: phase 2 dose–response studies. Environ Health Perspect 115:671–678; doi:10.1289/ehp.9666.
Pavuk M, Cerhan JR, Lynch CF, Schecter A, Petrik J, Chovancova J, et al. 2004. Environmental exposure to PCBs and cancer incidence in eastern Slovakia. Chemosphere 54:1509–1520.
Plísková M, Vondrácek J, Canton RF, Nera J, Kocan A, Petrík J, et al. 2005. Impact of polychlorinated biphenyls contamination on estrogenic activity in human male serum. Environ Health Perspect 113:1277–1284; doi:10.1289/ehp.7745.
Porta M, Jariod M, López T, Pumarega J, Puigdomènech E, Marco E, et al. 2009. Correcting serum concentrations of organochlorine compounds by lipids: alternatives to the organochlorine/total lipids ratio. Environ Int 35:1080–1085.
Prins GS. 2008. Endocrine disruptors and prostate cancer risk. Endocr Relat Cancer 15:649–656.
Radice S, Chiesara E, Fucile S, Marabini L. 2008. Different effects of PCB101, PCB118, PCB138 and PCB153 alone or mixed in MCF-7 breast cancer cells. Food ChemToxicol 46:2561–2567.
Ritchie JM, Vial SL, Fuortes LJ, Guo H, Reedy VE, Smith EM. 2003. Organochlorines and risk of prostate cancer. J Occup Environ Med 45:692–702.
Ritchie JM, Vial SL, Fuortes LJ, Robertson LW, Guo H, Reedy VE, et al. 2005. Comparison of proposed frameworks for grouping polychlorinated biphenyl congener data applied to a case–control pilot study of prostate cancer. Environ Res 98:104–113.
Rubin DB. 1987. Multiple Imputation for Nonresponse in Surveys. New York:John Wiley & Sons, Inc.
Safe S. 1993. Toxicology, structure-function relationship, and human and environmental health impacts of polychlorinated biphenyls: progress and problems. Environ Health Perspect 100:259–268.
Sawada N, Iwasaki M, Inoue M, Itoh H, Sasazuki S, Yamaji T, et al. 2010. Plasma organochlorines and subsequent risk of prostate cancer in Japanese men: a nested case–control study. Environ Health Perspect 118:659–665; doi:10.1289/ehp.0901214.
Seaman SR, Bartlett JW, White JR. 2012. Multiple imputation of missing covariates with non-linear effects and interactions: an evaluation of statistical methods. BMC Med Res Methodol 12:46; doi:10.1186/1471-2288-12-46.
Siddiqui IA, Adhami VM, Afaq F, Ahmad N, Mukhtar H. 2004. Modulation of phosphatidylinositol-3-kinase/ protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. J Cell Biochem 91:232–242.
Soto AM, Sonnenschein C. 2010. Environmental causes of cancer: endocrine disruptors as carcinogens. Nat Rev Endocrinol 6:363–370.
Thompson CA, Zhang ZF, Arah OA. 2013. Competing risk bias to explain the inverse relationship between smoking and malignant melanoma. Eur J Epidemiol 28:557–567.
Van Buuren S, Boshuizen HC, Knook DL. 1999. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 18:681–694.
Verner MA, Bachelet D, McDougall R, Charbonneau M, Guénel P, Haddad S. 2011. A case study addressing the reliability of polychlorinated biphenyl levels measured at the time of breast cancer diagnosis in representing early-life exposure. Cancer Epidemiol Biomarkers Prev 20:281–286.
Weiss NS. 2003. Adjusting for screening history in epidemiologic studies of cancer: why, when, and how to do it. Am J Epidemiol 157:957–961.
White IR, Royston P, Wood AM. 2009. Multiple imputa-tion using chained equations: issues and guidance for practice. Stat Med 30:377–399.
World Health Organization. 2013. State of the Science of Endocrine Disrupting Chemicals—2012 (Bergman Å, Heindel JJ, Jobling S, Kidd KA, Zoeller RT, eds). Available: http://unep.org/pdf/9789241505031_eng.pdf [accessed 11 November 2014].
Xu X, Dailey AB, Talbott EO, Ilacqua VA, Kearney G, Asal NR. 2010. Associations of serum concentra-tions of organochlorine pesticides with breast cancer and prostate cancer in U.S. adults. Environ Health Perspect 118:60–66; doi:10.1289/ehp.0900919.
